BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 20170817)

  • 21. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
    Zecchin M; Di Lenarda A; Proclemer A; Faganello G; Facchin D; Petz E; Sinagra G
    Europace; 2004 Sep; 6(5):400-6. PubMed ID: 15294264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Long QT Syndrome.
    Vohra J
    Heart Lung Circ; 2007; 16 Suppl 3():S5-12. PubMed ID: 17627884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: multicenter study in Japan.
    Shimizu W; Horie M; Ohno S; Takenaka K; Yamaguchi M; Shimizu M; Washizuka T; Aizawa Y; Nakamura K; Ohe T; Aiba T; Miyamoto Y; Yoshimasa Y; Towbin JA; Priori SG; Kamakura S
    J Am Coll Cardiol; 2004 Jul; 44(1):117-25. PubMed ID: 15234419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
    Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
    Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sudden arrhythmia death syndrome: importance of the long QT syndrome.
    Meyer JS; Mehdirad A; Salem BI; Kulikowska A; Kulikowski P
    Am Fam Physician; 2003 Aug; 68(3):483-8. PubMed ID: 12924831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment "failures".
    Vincent GM; Schwartz PJ; Denjoy I; Swan H; Bithell C; Spazzolini C; Crotti L; Piippo K; Lupoglazoff JM; Villain E; Priori SG; Napolitano C; Zhang L
    Circulation; 2009 Jan; 119(2):215-21. PubMed ID: 19118258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of death in the long QT syndrome when a sibling has died.
    Kaufman ES; McNitt S; Moss AJ; Zareba W; Robinson JL; Hall WJ; Ackerman MJ; Benhorin J; Locati ET; Napolitano C; Priori SG; Schwartz PJ; Towbin JA; Vincent GM; Zhang L
    Heart Rhythm; 2008 Jun; 5(6):831-6. PubMed ID: 18534367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long QT syndrome and Brugada syndrome. Drugs, ablation or ICD?].
    Haverkamp W; Rolf S; Eckardt L; Mönnig G
    Herz; 2005 Mar; 30(2):111-8. PubMed ID: 15875099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for recurrent syncope and subsequent fatal or near-fatal events in children and adolescents with long QT syndrome.
    Liu JF; Jons C; Moss AJ; McNitt S; Peterson DR; Qi M; Zareba W; Robinson JL; Barsheshet A; Ackerman MJ; Benhorin J; Kaufman ES; Locati EH; Napolitano C; Priori SG; Schwartz PJ; Towbin J; Vincent M; Zhang L; Goldenberg I;
    J Am Coll Cardiol; 2011 Feb; 57(8):941-50. PubMed ID: 21329841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry.
    Schwartz PJ; Spazzolini C; Priori SG; Crotti L; Vicentini A; Landolina M; Gasparini M; Wilde AA; Knops RE; Denjoy I; Toivonen L; Mönnig G; Al-Fayyadh M; Jordaens L; Borggrefe M; Holmgren C; Brugada P; De Roy L; Hohnloser SH; Brink PA
    Circulation; 2010 Sep; 122(13):1272-82. PubMed ID: 20837891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful parental use of an automated external defibrillator for an infant with long-QT syndrome.
    Divekar A; Soni R
    Pediatrics; 2006 Aug; 118(2):e526-9. PubMed ID: 16816007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long QT syndrome in the postpartum period].
    Kukla P; Filipecki A; Jastrzebski M; Plato A; Kukla M; Malarczyk-Zaher B; Janowski M; Zienciuk A
    Kardiol Pol; 2009 Jul; 67(7):795-9; discussion 800. PubMed ID: 19650005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia.
    Hayashi M; Denjoy I; Extramiana F; Maltret A; Buisson NR; Lupoglazoff JM; Klug D; Hayashi M; Takatsuki S; Villain E; Kamblock J; Messali A; Guicheney P; Lunardi J; Leenhardt A
    Circulation; 2009 May; 119(18):2426-34. PubMed ID: 19398665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of change in posture and exercise on repolarization in patients with long QT syndrome with HERG channel mutations.
    Walker BD; Krahn AD; Klein GJ; Skanes AC; Yee R; Wang J; Hegele RA
    Can J Cardiol; 2005 Jan; 21(1):33-8. PubMed ID: 15685300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis.
    Aizer A; Stern EH; Gomes JA; Teirstein AS; Eckart RE; Mehta D
    Am J Cardiol; 2005 Jul; 96(2):276-82. PubMed ID: 16018857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advice for management of the long-QT patient.
    Donahue JK
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):902-4. PubMed ID: 20455972
    [No Abstract]   [Full Text] [Related]  

  • 38. Arrhythmogenic hereditary syndromes: Brugada Syndrome, long QT syndrome, short QT syndrome and CPVT.
    Schimpf R; Veltmann C; Wolpert C; Borggrefe M
    Minerva Cardioangiol; 2010 Dec; 58(6):623-36. PubMed ID: 21135804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study.
    Olshansky B; Poole JE; Johnson G; Anderson J; Hellkamp AS; Packer D; Mark DB; Lee KL; Bardy GH;
    J Am Coll Cardiol; 2008 Apr; 51(13):1277-82. PubMed ID: 18371559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical predictors of cardiac events in patients with isolated syncope and negative electrophysiologic study.
    Da Costa A; Gulian JL; Romeyer-Bouchard C; Messier M; Zarqane N; Samuel B; Khiel A; Isaaz K
    Int J Cardiol; 2006 Apr; 109(1):28-33. PubMed ID: 15975670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.